European Leukemia Trial Registry
Trial: MDS ATGCSA

More Details
Scientific Title Antithymocyte Globulin (ATG) and Cyclosporine (CSA) to Treat Patients with Myelodysplastic Syndrome (MDS)
Short Title MDS ATGCSA
Trialgroup Deutsche MDS
Type of Trial multicentric, randomized
Disease Myelodysplastic Syndrome(MDS) All subtypes
Age >= 18 years
Status Closed
Start of Recruitment 02.08.2000
Leader Passweg, Dr. Prof. med., Jakob
Contactperson

General Contact Person
Ganser, Prof. Dr. med., Arnold
Email: Ganser.Arnold@mh-hannover.de
Homepage: www.mh-hannover.de/kliniken/haemonko/index1.htm

General Contact Person
Hofmann , Prof. Dr. med., Wolf-K.
Tel: +49 (0)30 8445-3421
Fax: +49 (0)30 8445-3425
Email: W.K.Hofmann@charite.de

Shortprotocol Shortprotocol
Diagnostics

Histology
Pathologisches Institut der Universitšt Hannover

created 10.07.2006 Anja Hellenbrecht
changed 07.02.2013 Sina Hehn
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org